Uniunea Europeană -
română -
EMA (European Medicines Agency)
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - agenți antineoplazici - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
koselugo 10 mg
astrazeneca ab - suedia - selumetinibum - caps. - 10mg - inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
koselugo 25 mg
astrazeneca ab - suedia - selumetinibum - caps. - 25mg - inhibitori de protein-kinaza
Uniunea Europeană -
română -
EMA (European Medicines Agency)
cibinqo
pfizer europe ma eeig - abrocitinib - dermatita, atopică - alte preparate dermatologice - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenți antineoplazici - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sunitinib sandoz 12,5 mg
remedica ltd - cipru - sunitinibum - caps. - 12,5mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sunitinib sandoz 25 mg
remedica ltd - cipru - sunitinibum - caps. - 25mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sunitinib sandoz 37,5 mg
remedica ltd - cipru - sunitinibum - caps. - 37,5mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sunitinib sandoz 50 mg
remedica ltd - cipru - sunitinibum - caps. - 50mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sunitinib alvogen 12,5 mg
remedica ltd. - cipru - sunitinibum - caps. - 12,5mg - alte antineoplazice inhibitori de protein-kinaza